Amazon Q4 Preview: Asymmetric Downside If AWS Prints Below $34.9B In Revenue
seekingalpha.com
Want to monitor BMRN?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor BMRNbiomarin is a global pharmaceutical company focused on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases. we remain steadfast to our original mission—to bring new treatments to market that will make a big impact on small patient populations. these patient populations are mostly children, suffering from diseases so rare, that the entire patient population can number as few as 1,000 people worldwide.